BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Houdt PJ, Kallehauge JF, Tanderup K, Nout R, Zaletelj M, Tadic T, van Kesteren ZJ, van den Berg CAT, Georg D, Côté JC, Levesque IR, Swamidas J, Malinen E, Telliskivi S, Brynolfsson P, Mahmood F, van der Heide UA; EMBRACE Collaborative Group. Phantom-based quality assurance for multicenter quantitative MRI in locally advanced cervical cancer. Radiother Oncol 2020;153:114-21. [PMID: 32931890 DOI: 10.1016/j.radonc.2020.09.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Monti S, Pontillo G, Russo C, Cella L, Cocozza S, Palma G. RESUMEN: A flexible class of multi-parameter qMRI protocols. Phys Med 2021;88:23-36. [PMID: 34171573 DOI: 10.1016/j.ejmp.2021.04.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 van Houdt PJ, Yang Y, van der Heide UA. Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive Radiotherapy. Front Oncol 2020;10:615643. [PMID: 33585242 DOI: 10.3389/fonc.2020.615643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
3 Keenan KE, Gimbutas Z, Dienstfrey A, Stupic KF, Boss MA, Russek SE, Chenevert TL, Prasad PV, Guo J, Reddick WE, Cecil KM, Shukla-Dave A, Aramburu Nunez D, Shridhar Konar A, Liu MZ, Jambawalikar SR, Schwartz LH, Zheng J, Hu P, Jackson EF. Multi-site, multi-platform comparison of MRI T1 measurement using the system phantom. PLoS One 2021;16:e0252966. [PMID: 34191819 DOI: 10.1371/journal.pone.0252966] [Reference Citation Analysis]
4 Mo T, Brandal SHB, Köhn-luque A, Engebraaten O, Kristensen VN, Fleischer T, Hompland T, Seierstad T. Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer. Cancers 2022;14:1326. [DOI: 10.3390/cancers14051326] [Reference Citation Analysis]
5 Wang YF, Tadimalla S, Hayden AJ, Holloway L, Haworth A. Artificial intelligence and imaging biomarkers for prostate radiation therapy during and after treatment. J Med Imaging Radiat Oncol 2021. [PMID: 34060219 DOI: 10.1111/1754-9485.13242] [Reference Citation Analysis]
6 van Houdt PJ, Saeed H, Thorwarth D, Fuller CD, Hall WA, McDonald BA, Shukla-Dave A, Kooreman ES, Philippens MEP, van Lier ALHMW, Keesman R, Mahmood F, Coolens C, Stanescu T, Wang J, Tyagi N, Wetscherek A, van der Heide UA. Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group. Eur J Cancer 2021;153:64-71. [PMID: 34144436 DOI: 10.1016/j.ejca.2021.04.041] [Reference Citation Analysis]
7 Kron T, Fox C, Ebert MA, Thwaites D. Quality management in radiotherapy treatment delivery. J Med Imaging Radiat Oncol 2022;66:279-90. [PMID: 35243785 DOI: 10.1111/1754-9485.13348] [Reference Citation Analysis]
8 Thorwarth D, Low DA. Technical Challenges of Real-Time Adaptive MR-Guided Radiotherapy. Front Oncol 2021;11:634507. [PMID: 33763369 DOI: 10.3389/fonc.2021.634507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]